Chemical industry – Page 116
-
Business
ECHA finishes first combo review
The European Chemical Agency has looked at a group of phthalates as a combination when considering risks associated with exposure
-
Business
Pfizer to spin off animal health business
New company Zoetis should start independent trading by July 2013
-
Business
Three pronged approach puts brakes on US breast cancer
US approval for anti-HER2 therapy Perjeta (pertuzumab) against breast cancer
-
Business
More testing needed for ridaforolimus
Marketing approval for anti-cancer drug ridaforolimus has been held up in the US
-
Business
Coca-Cola collaborates on bio-PET project
Global drinks giant Coca-Cola is teaming up with Ford, Heinz, Nike and Procter & Gamble to increase the use of bio-based polyethylene terephthalate
-
Business
UK nuclear fuel site faces 2018 closure
The Thermal Oxide Reprocessing Plant (Thorp) at Sellafield in the UK will close in 2018
-
Business
Plastics makers to win from electric cars
Demand for lightweight plastics in electric vehicles to hit $73 million by 2017
-
FeatureFeeding a growing world
Pesticides play a vital role in food production. So do they really deserve their tarnished public image? Sarah Houlton investigates
-
Business
Takeda buys into Brazil for 540m reals
Multilab makes generics and over-the-counter branded products
-
Business
Solvay opens 200 employee Indian R&D centre
Belgian chemical company opens centre in Savli, Gujarat State
-
BusinessHDL drug class struggling after latest flop
The failure of another ‘good’ cholesterol-raising drug and a new genetic study casts shadow over HDL hypothesis
-
BusinessDrug watchdogs mark out global territory
US and European regulatory agencies are leading worldwide collaborations to ensure drugs from outside their borders are safe
-
News
Pharma firms see mixed fortunes in Quebec
Canada’s pharmaceutical and life sciences hub hit by cutbacks as effects of global slowdown continue to be felt
-
Business
Business roundup: May 2012
Pharmaceutical New cholesterol drugs on the horizon The new candidate reduced "bad" LDL cholesterol by 40-72% in the trial Sanofi has reported Phase II data for a new drug candidate for lowering cholesterol levels in patients already taking statins. Over an 8-12 week period, the candidate reduced ...
-
BusinessAstraZeneca seeks to refill dry pipeline with gout drug
UK pharma giant splashes out $1.26 billion on US gout specialist Ardea Biosciences
-
Business
US approves new anaemia drug
US authorities have approved Omontys (peginesatide) injections for treating anaemia in dialysis patients with chronic kidney disease
-
Business
Half of sun products have BASF UV filters
German chemical giant BASF says that 50% of all ‘sun care’ products sold today contain its organic UV-A filters
-
Business
Seroquel patent row continues
The legal tug of war over the right to sell generic versions of Seroquel (quetiapine) tablets continues